Carfilzomib
IRB00104234
Phase 1 small_molecule completed
Quick answer
Carfilzomib for Recurrent Plasma Cell Myeloma is a Phase 1 program (small_molecule) at ONCOLYTICS BIOTECH INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ONCOLYTICS BIOTECH INC
- Indication
- Recurrent Plasma Cell Myeloma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed